Wednesday, October 26, 2016

Bayer AG Third Quarter 2016 Results
and News Conference Call

Third quarter of 2016:

Bayer shows strong performance – Acquisition of Monsanto agreed

  • Group sales increase by 2.3 percent (Fx & portfolio adj. 3.5 percent) to EUR 11,262 million
  • Pharmaceuticals sustains very good business development
  • Moderate increase in sales at Consumer Health
  • Crop Science successful in a persistently difficult market environment
  • EBITDA before special items up by 6.0 percent to EUR 2,682 million
  • Net income improves by 18.8 percent to EUR 1,187 million
  • Core earnings per share increase by 2.4 percent to EUR 1.73
  • Forecast for core earnings per share raised
  • Agreed acquisition of Monsanto creates a global leader in agriculture » more

Links

Follow the coverage in our social media channels:

Twitter

Twitter
You will find the key statements on » Twitter


Facebook

Facebook
We invite you to become part of our community and discuss with us on » Facebook

Last updated: November 9, 2016 Copyright © Bayer AG
http://www.bayer.com